http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020042334-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6374205e92fbb618dd2b26143f0a88a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 |
| filingDate | 2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921bf651bf8c145df0d01804d4559517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30f0fb9e5310f0f082ee3daff253442c |
| publicationDate | 2002-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20020042334-A |
| titleOfInvention | Pharmaceutical compositions containing (3S,8aS)-hexahydro-3-(phenylmethyl)pyrrolo[1,2a]pyrazine-1,4-dione as a protease inhibitor |
| abstract | The present invention is used as a protease inhibitor of (3S, 8aS) -hexahydro-3- (phenylmethyl) pyrrolo [1,2a] pyrazine-1,4-dione compound (SMFEI02) represented by the following general formula (I). The pharmaceutical composition containing the same may be usefully used for the treatment and prevention of various protease related diseases including elastase.n n n (I) |
| priorityDate | 2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.